Publication

Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid beta-glucosidase residual activity levels

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Dependence of reversibility and progression of mouse neuronopathic Gaucher disease on acid beta-glucosidase residual activity levels

Chat with Graph Search

Longitudinal changes in MEG-based brain network topology of ALS patients with cognitive/behavioral impairment—An exploratory study

Ultrastructural characterization of tau pathology in the human post‐mortem Alzheimer’s disease brain

Large-scale in-silico analysis of CSF dynamics within the subarachnoid space of the optic nerve

Improved MR Detection of Optic Nerve Demyelination With MP2RAGE-FLAWS Compared With T2-Weighted Fat-Saturated Sequences

O-GlcNAc forces an α-synuclein amyloid strain with notably diminished seeding and pathology

Distinct ultrastructural phenotypes of glial and neuronal alpha-synuclein inclusions in multiple system atrophy

Brain matters: unveiling the distinct contributions of region, age, and sex to glia diversity and CNS function

Brain mitochondrial diversity and network organization predict anxiety-like behavior in male mice

Digital reconstruction of the mammalian spinal cord: from anatomical reference volume to cell type atlas of the mouse spinal cord

Loss of Motor Cortical Inputs to the Red Nucleus after CNS Disorders in Nonhuman Primates

Overexpression of human alpha-Synuclein leads to dysregulated microbiome/metabolites with ageing in a rat model of Parkinson disease

Comprehensive proteomic analysis of JC polyomavirus-infected human astrocytes and their extracellular vesicles

Deconstructing and Reconstructing the Complexity of Tau pathology

Pathological substrate of memory impairment in multiple system atrophy

Elezanumab, a human anti-RGMa monoclonal antibody, promotes neuroprotection, neuroplasticity, and neurorecovery following a thoracic hemicompression spinal cord injury in non-human primates

Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson's disease and other synucleinopathies

Tau seeds from patients induce progressive supranuclear palsy pathology and symptoms in primates

Structural architecture of the Neuronal-Glial-Vascular system

Capturing the heterogeneity of alpha-synuclein pathology in synucleinopathies

Reverse engineering Lewy bodies: how far have we come and how far can we go?